Niraj Vasisht is the new chief technical officer at BioDelivery Sciences International (Nasdaq: BDSI).

is developing a breakthrough pain drug called Onsolis. Vasisht has been involved in the progress of Onsolis, formerly known as Bema Fentanyl. His earlier role at the firm was vice president of product development.

The chief technical officer is a new position for the company.

BDSI plans to launch Onsolis in 2009.